VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $31,505 | +249.6% | 252,033 | +188.0% | 0.00% | – |
| Q4 2022 | $9,013 | -82.0% | 87,506 | -73.4% | 0.00% | – |
| Q3 2022 | $50,000 | -42.5% | 329,205 | +231.8% | 0.00% | – |
| Q2 2022 | $87,000 | -37.9% | 99,209 | -11.8% | 0.00% | – |
| Q1 2022 | $140,000 | -42.6% | 112,510 | -10.0% | 0.00% | – |
| Q4 2021 | $244,000 | -25.2% | 125,021 | +5.2% | 0.00% | – |
| Q3 2021 | $326,000 | -44.6% | 118,795 | -36.3% | 0.00% | – |
| Q2 2021 | $588,000 | – | 186,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|